Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy for weight loss in trial – Reuters By Weight Loss Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy for weight loss in trial Reuters Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs NBC News Mounjaro vs Wegovy: Weight-loss drugs in head-to-head trial BBC Brought to you by Google News. Read the rest of the article here Facebook Twitter Pinterest